Last reviewed · How we verify
Injection of allogeneic neuroblastoma cells
Injection of allogeneic neuroblastoma cells is a Biologic drug developed by Baylor College of Medicine. It is currently in Phase 1 development.
At a glance
| Generic name | Injection of allogeneic neuroblastoma cells |
|---|---|
| Sponsor | Baylor College of Medicine |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- MIBG for Refractory Neuroblastoma and Pheochromocytoma (NA)
- Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma (PHASE1, PHASE2)
- Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma (PHASE1)
- Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) (PHASE2)
- Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL (PHASE1)
- Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma (PHASE2)
- Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Injection of allogeneic neuroblastoma cells CI brief — competitive landscape report
- Injection of allogeneic neuroblastoma cells updates RSS · CI watch RSS
- Baylor College of Medicine portfolio CI
Frequently asked questions about Injection of allogeneic neuroblastoma cells
What is Injection of allogeneic neuroblastoma cells?
Injection of allogeneic neuroblastoma cells is a Biologic drug developed by Baylor College of Medicine.
Who makes Injection of allogeneic neuroblastoma cells?
Injection of allogeneic neuroblastoma cells is developed by Baylor College of Medicine (see full Baylor College of Medicine pipeline at /company/baylor-college-of-medicine).
What development phase is Injection of allogeneic neuroblastoma cells in?
Injection of allogeneic neuroblastoma cells is in Phase 1.
Related
- Manufacturer: Baylor College of Medicine — full pipeline